Literature DB >> 1671647

MYC rearrangement and translocations involving band 8q24 in diffuse large cell lymphomas.

M Ladanyi1, K Offit, S C Jhanwar, D A Filippa, R S Chaganti.   

Abstract

The configuration of the MYC gene in diffuse large cell lymphomas (DLCL) with translocations involving band 8q24 [t(8q24)] has not been systematically studied. We collected cytogenetic and clinical data on 171 consecutive cases of DLCL, including cleaved, noncleaved, and immunoblastic types, of which 96 had DNA available and 124 had abnormal karyotypes. The cases with DNA available were evaluated for MYC rearrangement (MYC-R) by Southern hybridization of EcoRI-digested tumor DNA using an exon-1 probe, a combination of probe and enzyme known to detect over 85% of breaks in sporadic Burkitt's lymphoma. In cases studied at diagnosis, MYC-R, t(8;14)(q24;q32), or other t(8q24) were not prognostically significant. Among the 124 cases with karyotypic abnormalities, seropositivity for human immunodeficiency virus was significantly more common in cases with a t(8q24) (72%) than in cases without it (9%) (P less than .05). Of the four cases with an MYC -R, two had a t(8;14), one had a t(7;8;14)(p15;q24;q32), and one had a t(8;?)(q24;?) and a del(8)(q24). In the three previous cases with translocations involving 8q24 and 14q32, comigration of the rearranged MYC band with either the J region or the switch-mu region of the Ig heavy chain gene could not be demonstrated, leaving the 14q32 breakpoint undefined at the molecular level. Among the remaining 72 cases where both an abnormal karyotype and molecular data were available, 11 had a t(8q24), either t(8;14) or t(8;22)(q24;q11), in the absence of an MYC-R. In these cases, the 8q24 break was presumably located outside of the EcoRI MYC fragment. All 15 cases with a t(8q24) were also screened for point mutations in the PvuII site in the first exon of MYC; two cases that were not MYC-R showed loss of this restriction site. These results indicate that in most DLCL with t(8;14) or other t(8q24), the 8q24 breakpoint lies away from the MYC gene; in a minority of these cases, point mutations in regulatory noncoding regions were detected.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1671647

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  17 in total

1.  Expression of Myc, but not pSTAT3, is an adverse prognostic factor for diffuse large B-cell lymphoma treated with epratuzumab/R-CHOP.

Authors:  Mamta Gupta; Matthew J Maurer; Linda E Wellik; Mark E Law; Jing Jing Han; Nazan Ozsan; Ivana N Micallef; Ahmet Dogan; Thomas E Witzig
Journal:  Blood       Date:  2012-09-27       Impact factor: 22.113

2.  Definition of MYC genetic heteroclonality in diffuse large B-cell lymphoma with 8q24 rearrangement and its impact on protein expression.

Authors:  Alexandra Valera; Samantha Epistolio; Lluis Colomo; Alice Riva; Olga Balagué; Ivan Dlouhy; Alexandar Tzankov; Marco Bühler; Eugenia Haralambieva; Elias Campo; Davide Soldini; Luca Mazzucchelli; Vittoria Martin
Journal:  Mod Pathol       Date:  2016-04-29       Impact factor: 7.842

Review 3.  Management of Patients with MYC-Altered Lymphomas.

Authors:  Daniel J Landsburg
Journal:  Curr Hematol Malig Rep       Date:  2016-06       Impact factor: 3.952

4.  BCL8, a novel gene involved in translocations affecting band 15q11-13 in diffuse large-cell lymphoma.

Authors:  V G Dyomin; P H Rao; R Dalla-Favera; R S Chaganti
Journal:  Proc Natl Acad Sci U S A       Date:  1997-05-27       Impact factor: 11.205

5.  Tumor formation and inactivation of RIZ1, an Rb-binding member of a nuclear protein-methyltransferase superfamily.

Authors:  G Steele-Perkins; W Fang; X H Yang; M Van Gele; T Carling; J Gu; I M Buyse; J A Fletcher; J Liu; R Bronson; R B Chadwick; A de la Chapelle; X Zhang; F Speleman; S Huang
Journal:  Genes Dev       Date:  2001-09-01       Impact factor: 11.361

Review 6.  Molecular pathogenesis of diffuse large B-cell lymphoma.

Authors:  Christof Schneider; Laura Pasqualucci; Riccardo Dalla-Favera
Journal:  Semin Diagn Pathol       Date:  2011-05       Impact factor: 3.464

7.  De novo CD5-positive and Richter's syndrome-associated diffuse large B cell lymphomas are genotypically distinct.

Authors:  A Matolcsy; A Chadburn; D M Knowles
Journal:  Am J Pathol       Date:  1995-07       Impact factor: 4.307

Review 8.  Utility of immunohistochemistry with an antibody against MYC at the initial diagnosis of follicular lymphoma, grade 3A, for predicting a more aggressive clinical course: a case report and review of the literature.

Authors:  Kunimoto Ichikawa; Nanae Aritaka; Kanako Ogura; Masaru Hosone; Yasunori Ota; Eriko Sato; Norio Komatsu; Takao Hirano
Journal:  Int J Clin Exp Pathol       Date:  2015-06-01

Review 9.  Pitfalls in diagnostic hematopathology -- Part II.

Authors:  Xianfeng F Zhao
Journal:  Int J Clin Exp Pathol       Date:  2009-09-10

10.  Pediatric post-transplant diffuse large B cell lymphoma after cardiac transplantation.

Authors:  Shigenori Kusuki; Yoshiko Hashii; Norihide Fukushima; Sachiko Takizawa; Sadao Tokimasa; Shigetoyo Kogaki; Hideaki Ohta; Etsuko Tsuda; Atsuko Nakagawa; Keiichi Ozono
Journal:  Int J Hematol       Date:  2009-01-21       Impact factor: 2.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.